Table 1.
Demographic, clinical, and laboratory data at baseline in 8,954 patients on peritoneal dialysis.
| Variable | |
|---|---|
| Patients (n) | 8,954 |
| Age (years) | 62.7 ± 13.1 |
| Male sex (%) | 63.8 |
| Dialysis duration (months) | 33 [15–60] |
| Primary cause of ESKD, n (%) | |
| Chronic glomerulonephritis | 3,513 (39.2) |
| Diabetic nephropathy | 2,710 (30.3) |
| Hypertension | 1,154 (12.9) |
| Polycystic kidney disease | 223 (2.5) |
| Other | 476 (5.3) |
| Unknown | 878 (9.8) |
| Body mass index (kg/m2) | 23.4 ± 3.8 |
| Smoking (%) | 8.1 |
| Antihypertensive agents (%) | 79.2 |
| Comorbid CVD (%) | 15.1 |
| Hemoglobin (g/dL) | 10.8 ± 1.4 |
| Albumin (g/dL) | 3.3 ± 0.5 |
| Non-HDL cholesterol (mg/dL) | 128 ± 37 |
| HDL cholesterol (mg/dL) | 50 ± 18 |
| C-reactive protein (mg/dL) | 0.13 [0.07–0.40] |
| Calcium (mg/dL) | 8.7 ± 0.8 |
| Phosphate (mg/dL) | 5.2 ± 1.3 |
| Intact PTH (pg/mL) | 155 [81–262] |
| Renal Kt/V | 0.3 [0–0.8] |
| PD Kt/V | 1.4 ± 0.6 |
| Total Kt/V | 1.8 ± 0.8 |
| D/P Cr | 0.65 ± 0.13 |
| Use of 2.5% glucose dialysate (%) | 37.5 |
| Use of icodextrin (%) | 40.8 |
| Use of automated PD (%) | 43.2 |
| Connecting system (%) | |
| Device (+) | 68.2 |
| PD + HD combination (%) | 18.8 |
Data are presented as the number, percentage, mean ± standard deviation, or median [interquartile range]. Cr, creatinine; CVD, cardiovascular disease; D/P, dialysate/plasma; ESKD, end-stage kidney disease; HD, hemodialysis; HDL, high-density lipoprotein; PD, peritoneal dialysis; PTH, parathyroid hormone.